As of March 23, 2026, Supernus Pharmaceuticals's top three insider holders are Jack A. Khattar (President, Ceo, 1.23Mn shares), Jack A. Khattar (President, Ceo, 1.01Mn shares), Tami Tillotson Martin (Sr. V.P., Regulatory Affairs, 86.93K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Jack A. Khattar | President, Ceo | 1,241,144 | 958,100 | 16 Mar, 2026 |
| Jack A. Khattar | President, Ceo | 1,228,644 | 0 | 10 Mar, 2026 |
| Jack A. Khattar | President, Ceo | 0 | 1,005,600 | 03 Apr, 2025 |
| Tami Tillotson Martin | Sr. V.P., Regulatory Affairs | 86,933 | 0 | 27 Feb, 2024 |
| Frederick M. Hudson | 65,782 | 0 | 25 Feb, 2026 | |
| Frederick M. Hudson | 60,413 | 0 | 16 Mar, 2026 | |
| Georges Gemayel | 27,277 | 0 | 09 Mar, 2026 | |
| Carrolee Barlow | 27,045 | 0 | 25 Feb, 2026 | |
| Frank Mottola | Svp, Chief Tech. Ops. Officer | 18,440 | 0 | 10 Mar, 2026 |
| Padmanabh P. Bhatt | Sr. Vp Of Ip, Cso | 17,044 | 0 | 26 Feb, 2026 |
| Padmanabh P. Bhatt | Sr. Vp Of Ip, Cso | 17,044 | 0 | 18 Mar, 2026 |
| Jonathan Rubin | Svp, Chief Medical Officer | 13,341 | 0 | 26 Feb, 2026 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 16 Mar, 2026 | Padmanabh P. Bhatt | Common Stock | A | 22,750 | $36.75 | 39,794 | D | M |
| 16 Mar, 2026 | Padmanabh P. Bhatt | Common Stock | A | 4,250 | $29.61 | 44,044 | D | M |
| 16 Mar, 2026 | Padmanabh P. Bhatt | Common Stock | A | 18,000 | $32.20 | 62,044 | D | M |
| 16 Mar, 2026 | Padmanabh P. Bhatt | Common Stock | A | 5,000 | $27.94 | 67,044 | D | M |
| 16 Mar, 2026 | Padmanabh P. Bhatt | Common Stock | D | 34,114 | $50.18 | 32,930 | D | S |
| 16 Mar, 2026 | Padmanabh P. Bhatt | Common Stock | D | 15,886 | $50.49 | 17,044 | D | S |
| 17 Mar, 2026 | Padmanabh P. Bhatt | Common Stock | A | 22,750 | $39.40 | 39,794 | D | M |
| 17 Mar, 2026 | Padmanabh P. Bhatt | Common Stock | A | 12,250 | $36.75 | 52,044 | D | M |
| 17 Mar, 2026 | Padmanabh P. Bhatt | Common Stock | A | 15,000 | $38.60 | 67,044 | D | M |
| 17 Mar, 2026 | Padmanabh P. Bhatt | Common Stock | D | 27,710 | $49.95 | 39,334 | D | S |
| 17 Mar, 2026 | Padmanabh P. Bhatt | Common Stock | D | 22,290 | $50.73 | 17,044 | D | S |
| 18 Mar, 2026 | Padmanabh P. Bhatt | Common Stock | A | 7,250 | $39.40 | 24,294 | D | M |
| 18 Mar, 2026 | Padmanabh P. Bhatt | Common Stock | D | 6,838 | $49.55 | 17,456 | D | S |
| 18 Mar, 2026 | Padmanabh P. Bhatt | Common Stock | D | 412 | $50.48 | 17,044 | D | S |
| 16 Mar, 2026 | Padmanabh P. Bhatt | Employee Stock Option (Right to Buy) | D | 22,750 | $0.00 | 12,250 | D | M |
| 16 Mar, 2026 | Padmanabh P. Bhatt | Employee Stock Option (Right to Buy) | D | 4,250 | $0.00 | 0 | D | M |
| 16 Mar, 2026 | Padmanabh P. Bhatt | Employee Stock Option (Right to Buy) | D | 18,000 | $0.00 | 0 | D | M |
| 16 Mar, 2026 | Padmanabh P. Bhatt | Employee Stock Option (Right to Buy) | D | 5,000 | $0.00 | 15,000 | D | M |
| 17 Mar, 2026 | Padmanabh P. Bhatt | Employee Stock Option (Right to Buy) | D | 22,750 | $0.00 | 7,250 | D | M |
| 17 Mar, 2026 | Padmanabh P. Bhatt | Employee Stock Option (Right to Buy) | D | 12,250 | $0.00 | 0 | D | M |